| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.75 | 0.005 | 0.75 | 5 Hydroxytryptamine release stimulant | 0.359 0.054 CID_9816279 | ||
| 0.741 | 0.019 | 0.741 | Caspase 9 stimulant | 0.698 0.024 CID_9816279 | ||
| 0.612 | 0.015 | 0.644 | Vasodilator, peripheral | 0.644 0.011 CID_9816279 | CID_9816279 | |
| 0.509 | 0.03 | 0.509 | 5 Hydroxytryptamine release inhibitor | 0.469 0.044 CID_9816279 | ||
| 0.516 | 0.042 | 0.516 | Transcription factor NF kappa B inhibitor | 0.465 0.05 CID_9816279 | ||
| 0.493 | 0.034 | 0.537 | Aldehyde oxidase inhibitor | 0.537 0.028 CID_9816279 | CID_9816279 | |
| 0.445 | 0.009 | 0.445 | Non-steroidal antiinflammatory agent | 0.386 0.015 CID_9816279 | ||
| 0.473 | 0.04 | 0.473 | Immunosuppressant | 0.438 0.051 CID_9816279 | ||
| 0.421 | 0.01 | 0.46 | Melanin inhibitor | 0.46 0.009 CID_9816279 | CID_9816279 | |
| 0.497 | 0.089 | 0.497 | Antiinflammatory | 0.446 0.112 CID_9816279 | ||
| 0.426 | 0.022 | 0.426 | Superoxide dismutase inhibitor | 0.307 0.048 CID_9816279 | ||
| 0.414 | 0.026 | 0.414 | Free radical scavenger | 0.288 0.055 CID_9816279 | ||
| 0.416 | 0.034 | 0.416 | Lipoxygenase inhibitor | 0.315 0.064 CID_9816279 | ||
| 0.399 | 0.016 | 0.403 | Anesthetic general | 0.403 0.016 CID_9816279 | CID_9816279 | |
| 0.382 | 0.004 | 0.382 | TRPA1 agonist | 0.16 0.025 CID_9816279 | ||
| 0.382 | 0.018 | 0.382 | 5 Hydroxytryptamine uptake stimulant | 0.27 0.064 CID_9816279 | ||
| 0.451 | 0.091 | 0.549 | Apoptosis agonist | 0.549 0.061 CID_9816279 | CID_9816279 | |
| 0.36 | 0.008 | 0.36 | Neurotrophic factor enhancer | 0.284 0.023 CID_9816279 | ||
| 0.363 | 0.013 | 0.363 | Monophenol monooxygenase inhibitor | 0.325 0.015 CID_9816279 | ||
| 0.378 | 0.031 | 0.378 | Tumour necrosis factor alpha release inhibitor | 0.188 0.119 CID_9816279 | ||
| 0.359 | 0.018 | 0.359 | Platelet adhesion inhibitor | 0.337 0.023 CID_9816279 | ||
| 0.363 | 0.023 | 0.393 | Cyclic AMP phosphodiesterase inhibitor | 0.393 0.018 CID_9816279 | CID_9816279 | |
| 0.402 | 0.075 | 0.43 | Histamine release inhibitor | 0.43 0.06 CID_9816279 | CID_9816279 | |
| 0.365 | 0.042 | 0.365 | Antioxidant | 0.281 0.069 CID_9816279 | ||
| 0.402 | 0.08 | 0.536 | Calcium channel L-type activator | 0.536 0.016 CID_9816279 | CID_9816279 | |
| 0.366 | 0.054 | 0.366 | Caspase 3 stimulant | 0.304 0.076 CID_9816279 | ||
| 0.324 | 0.023 | 0.324 | Tyrosine 3 hydroxylase inhibitor | 0.223 0.099 CID_9816279 | ||
| 0.306 | 0.01 | 0.325 | Succinate dehydrogenase inhibitor | 0.325 0.007 CID_9816279 | CID_9816279 | |
| 0.352 | 0.063 | 0.503 | Cholesterol antagonist | 0.503 0.032 CID_9816279 | CID_9816279 | |
| 0.342 | 0.055 | 0.356 | Calcium channel activator | 0.356 0.046 CID_9816279 | CID_9816279 | |
| 0.339 | 0.056 | 0.477 | Spasmolytic | 0.477 0.026 CID_9816279 | CID_9816279 | |
| 0.324 | 0.042 | 0.324 | Pyruvate kinase inhibitor | 0.199 0.081 CID_9816279 | ||
| 0.288 | 0.015 | 0.288 | Phospholipase A2 inhibitor | 0.25 0.023 CID_9816279 | ||
| 0.33 | 0.067 | 0.33 | Apoptosis antagonist | 0.307 0.081 CID_9816279 | ||
| 0.308 | 0.054 | 0.308 | Insulysin inhibitor | 0.187 0.177 CID_9816279 | ||
| 0.326 | 0.074 | 0.356 | Antithrombotic | 0.356 0.062 CID_9816279 | CID_9816279 | |
| 0.279 | 0.044 | 0.279 | Nitric oxide antagonist | 0.232 0.057 CID_9816279 | ||
| 0.255 | 0.022 | 0.255 | Cytokine production inhibitor | 0.123 0.086 CID_9816279 | ||
| 0.286 | 0.053 | 0.321 | Vasodilator | 0.321 0.042 CID_9816279 | CID_9816279 | |
| 0.275 | 0.044 | 0.275 | Sigma receptor agonist | |||
| 0.244 | 0.019 | 0.244 | Aldehyde dehydrogenase inhibitor | 0.16 0.042 CID_9816279 | ||
| 0.23 | 0.007 | 0.23 | HIV-1 integrase (Overall Integration) inhibitor | 0.203 0.011 CID_9816279 | ||
| 0.267 | 0.045 | 0.267 | Platelet aggregation inhibitor | |||
| 0.298 | 0.081 | 0.298 | 12-Lipoxygenase inhibitor | 0.194 0.159 CID_9816279 | ||
| 0.244 | 0.028 | 0.244 | Lipid peroxidase inhibitor | 0.151 0.068 CID_9816279 | ||
| 0.246 | 0.032 | 0.246 | Tumour necrosis factor antagonist | |||
| 0.213 | 0.005 | 0.213 | DOPA decarboxylase inhibitor | 0.145 0.024 CID_9816279 | ||
| 0.202 | 0.008 | 0.25 | Electron transport complex I inhibitor | 0.25 0.005 CID_9816279 | CID_9816279 | |
| 0.289 | 0.097 | 0.339 | Vasodilator, coronary | 0.339 0.061 CID_9816279 | CID_9816279 | |
| 0.199 | 0.007 | 0.199 | Vanilloid agonist | |||
| 0.314 | 0.122 | 0.314 | 15-Lipoxygenase inhibitor | |||
| 0.284 | 0.094 | 0.305 | Sodium/bile acid cotransporter inhibitor | 0.305 0.074 CID_9816279 | CID_9816279 | |
| 0.212 | 0.022 | 0.212 | Arachidonic acid antagonist | 0.203 0.03 CID_9816279 | ||
| 0.201 | 0.013 | 0.201 | Calcium antagonist | 0.15 0.023 CID_9816279 | ||
| 0.197 | 0.009 | 0.197 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.082 CID_9816279 | ||
| 0.267 | 0.086 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.384 0.034 CID_9816279 | CID_9816279 | |
| 0.231 | 0.052 | 0.263 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.263 0.037 CID_9816279 | CID_9816279 | |
| 0.199 | 0.025 | 0.199 | Cystathionine beta-synthase inhibitor | 0.135 0.048 CID_9816279 | ||
| 0.189 | 0.015 | 0.189 | Vanilloid 1 agonist | 0.119 0.089 CID_9816279 | ||
| 0.2 | 0.029 | 0.2 | MAO A inhibitor | |||
| 0.248 | 0.077 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.155 CID_9816279 | ||
| 0.185 | 0.015 | 0.185 | Phosphodiesterase IV inhibitor | 0.131 0.029 CID_9816279 | ||
| 0.189 | 0.02 | 0.202 | Carbonic anhydrase XV inhibitor | 0.202 0.018 CID_9816279 | CID_9816279 | |
| 0.249 | 0.08 | 0.249 | Gastrin inhibitor | |||
| 0.183 | 0.017 | 0.183 | Photosensitizer | 0.155 0.028 CID_9816279 | ||
| 0.191 | 0.028 | 0.191 | Toll-Like receptor 2 antagonist | 0.151 0.052 CID_9816279 | ||
| 0.183 | 0.021 | 0.387 | Bronchodilator | 0.387 0.006 CID_9816279 | CID_9816279 | |
| 0.224 | 0.066 | 0.224 | Amyloid beta aggregation inhibitor | 0.191 0.083 CID_9816279 | ||
| 0.192 | 0.039 | 0.192 | Tubulin antagonist | 0.14 0.063 CID_9816279 | ||
| 0.266 | 0.113 | 0.266 | Thyroid hormone antagonist | |||
| 0.261 | 0.112 | 0.261 | Thyroid hormone beta antagonist | |||
| 0.183 | 0.036 | 0.183 | Neurotrophic factor | 0.14 0.069 CID_9816279 | ||
| 0.151 | 0.005 | 0.151 | Granulocyte macrophage colony stimulating factor agonist | 0.13 0.011 CID_9816279 | ||
| 0.227 | 0.087 | 0.227 | Calpain inhibitor | 0.175 0.141 CID_9816279 | ||
| 0.157 | 0.019 | 0.157 | Porphobilinogen synthase inhibitor | 0.093 0.039 CID_9816279 | ||
| 0.176 | 0.04 | 0.176 | CF transmembrane conductance regulator agonist | |||
| 0.183 | 0.046 | 0.183 | MAO inhibitor | |||
| 0.165 | 0.03 | 0.165 | Falcipain 3 inhibitor | |||
| 0.15 | 0.016 | 0.15 | Acetylcholine release stimulant | 0.119 0.05 CID_9816279 | ||
| 0.169 | 0.035 | 0.191 | Farnesoid X receptor antagonist | 0.191 0.024 CID_9816279 | CID_9816279 | |
| 0.267 | 0.137 | 0.267 | Calpain 2 inhibitor | 0.266 0.138 CID_9816279 | ||
| 0.167 | 0.037 | 0.193 | Cholesterol synthesis inhibitor | 0.193 0.028 CID_9816279 | CID_9816279 | |
| 0.166 | 0.038 | 0.166 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.173 | 0.045 | 0.173 | Interleukin 1 antagonist | |||
| 0.146 | 0.02 | 0.146 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.113 0.032 CID_9816279 | ||
| 0.141 | 0.018 | 0.141 | Macrophage migration inhibitory factor inhibitor | 0.089 0.042 CID_9816279 | ||
| 0.168 | 0.045 | 0.197 | Acetylcholinesterase inhibitor | 0.197 0.034 CID_9816279 | CID_9816279 | |
| 0.134 | 0.012 | 0.134 | TRPA1 antagonist | |||
| 0.19 | 0.071 | 0.206 | P-glycoprotein inhibitor | 0.206 0.06 CID_9816279 | CID_9816279 | |
| 0.191 | 0.071 | 0.191 | Hepatoprotectant | 0.175 0.084 CID_9816279 | ||
| 0.196 | 0.077 | 0.245 | Insulin sensitizer | 0.245 0.037 CID_9816279 | CID_9816279 | |
| 0.131 | 0.013 | 0.131 | Bile acid receptor antagonist | 0.118 0.022 CID_9816279 | ||
| 0.202 | 0.085 | 0.223 | Nitric-oxide synthase stimulant | 0.223 0.056 CID_9816279 | CID_9816279 | |
| 0.197 | 0.081 | 0.197 | DNA methylase inhibitor | |||
| 0.132 | 0.016 | 0.132 | Aromatase inhibitor | 0.065 0.038 CID_9816279 | ||
| 0.153 | 0.037 | 0.153 | 5-Lipoxygenase inhibitor | 0.109 0.057 CID_9816279 | ||
| 0.158 | 0.042 | 0.167 | Cyclooxygenase 3 inhibitor | 0.167 0.035 CID_9816279 | CID_9816279 | |
| 0.143 | 0.029 | 0.143 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 CID_9816279 | ||
| 0.152 | 0.039 | 0.152 | Interleukin 1b antagonist | 0.144 0.045 CID_9816279 | ||
| 0.135 | 0.023 | 0.135 | Thioredoxin inhibitor | |||
| 0.138 | 0.025 | 0.154 | Anabolic | 0.154 0.016 CID_9816279 | CID_9816279 | |
| 0.166 | 0.057 | 0.166 | Thiol protease inhibitor | |||
| 0.138 | 0.03 | 0.198 | Sphingomyelinase inhibitor | 0.198 0.01 CID_9816279 | CID_9816279 | |
| 0.127 | 0.019 | 0.127 | Keratolytic | 0.089 0.038 CID_9816279 | ||
| 0.176 | 0.069 | 0.176 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.165 | 0.059 | 0.192 | Protein kinase stimulant | 0.192 0.045 CID_9816279 | CID_9816279 | |
| 0.117 | 0.015 | 0.117 | T cell inhibitor | 0.083 0.056 CID_9816279 | ||
| 0.125 | 0.025 | 0.125 | CYP2A6 inhibitor | |||
| 0.148 | 0.048 | 0.148 | Cathepsin H inhibitor | |||
| 0.199 | 0.1 | 0.199 | Antiamyloidogenic | 0.191 0.106 CID_9816279 | ||
| 0.126 | 0.028 | 0.126 | Carbonic anhydrase XIII inhibitor | 0.125 0.028 CID_9816279 | ||
| 0.101 | 0.003 | 0.101 | Melatonin receptor 1A agonist | 0.036 0.018 CID_9816279 | ||
| 0.104 | 0.009 | 0.104 | Glutamate (mGluR7) antagonist | 0.076 0.033 CID_9816279 | ||
| 0.107 | 0.013 | 0.112 | Peroxisome proliferator-activated receptor gamma antagonist | 0.112 0.011 CID_9816279 | CID_9816279 | |
| 0.109 | 0.016 | 0.109 | Estrogen-related receptor beta agonist | 0.091 0.038 CID_9816279 | ||
| 0.175 | 0.083 | 0.175 | DNA methyltransferase I inhibitor | |||
| 0.106 | 0.014 | 0.106 | Alpha tubulin antagonist | 0.068 0.025 CID_9816279 | ||
| 0.247 | 0.157 | 0.247 | GABA C receptor rho-3 antagonist | |||
| 0.099 | 0.009 | 0.099 | Oleamide hydrolase inhibitor | 0.067 0.017 CID_9816279 | ||
| 0.123 | 0.033 | 0.123 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.058 CID_9816279 | ||
| 0.123 | 0.033 | 0.123 | Alcohol dehydrogenase inhibitor | |||
| 0.107 | 0.019 | 0.14 | Leukotriene antagonist | 0.14 0.012 CID_9816279 | CID_9816279 | |
| 0.154 | 0.067 | 0.154 | Cyclooxygenase inhibitor | |||
| 0.094 | 0.007 | 0.094 | Calcium channel P-type blocker | 0.072 0.024 CID_9816279 | ||
| 0.154 | 0.068 | 0.154 | GABA C receptor rho-2 antagonist | |||
| 0.115 | 0.029 | 0.115 | Phosphodiesterase 6D inhibitor | 0.093 0.068 CID_9816279 | ||
| 0.099 | 0.016 | 0.099 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.159 | 0.075 | 0.159 | Thrombolytic | 0.135 0.094 CID_9816279 | ||
| 0.139 | 0.056 | 0.21 | Antibacterial (Helicobacter pylori) | 0.21 0.02 CID_9816279 | CID_9816279 | |
| 0.181 | 0.098 | 0.181 | Histone acetyltransferase inhibitor | |||
| 0.125 | 0.042 | 0.125 | Beta glucuronidase inhibitor | 0.098 0.072 CID_9816279 | ||
| 0.111 | 0.03 | 0.118 | Glutamate release inhibitor | 0.118 0.023 CID_9816279 | CID_9816279 | |
| 0.166 | 0.085 | 0.167 | Lipocortins synthesis antagonist | 0.167 0.084 CID_9816279 | CID_9816279 | |
| 0.178 | 0.098 | 0.255 | Interleukin antagonist | 0.255 0.06 CID_9816279 | CID_9816279 | |
| 0.124 | 0.044 | 0.124 | Butyrylcholinesterase inhibitor | |||
| 0.147 | 0.068 | 0.168 | Adenylate cyclase stimulant | 0.168 0.038 CID_9816279 | CID_9816279 | |
| 0.091 | 0.012 | 0.148 | Leukotriene B4 antagonist | 0.148 0.005 CID_9816279 | CID_9816279 | |
| 0.115 | 0.036 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.112 0.039 CID_9816279 | ||
| 0.159 | 0.081 | 0.159 | Neurotensin receptor agonist | |||
| 0.199 | 0.121 | 0.199 | Neuropeptide Y2 antagonist | 0.175 0.17 CID_9816279 | ||
| 0.129 | 0.051 | 0.129 | Interleukin 8 antagonist | |||
| 0.132 | 0.057 | 0.132 | Proteasome inhibitor | |||
| 0.108 | 0.036 | 0.128 | Ornithine decarboxylase inhibitor | 0.128 0.021 CID_9816279 | CID_9816279 | |
| 0.135 | 0.065 | 0.135 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.118 | 0.049 | 0.137 | Mediator release inhibitor | 0.137 0.035 CID_9816279 | CID_9816279 | |
| 0.073 | 0.004 | 0.073 | Cyclophilin A inhibitor | 0.044 0.009 CID_9816279 | ||
| 0.096 | 0.03 | 0.096 | Peroxisome proliferator-activated receptor gamma agonist | 0.076 0.044 CID_9816279 | ||
| 0.147 | 0.082 | 0.147 | Interferon gamma antagonist | 0.144 0.086 CID_9816279 | ||
| 0.084 | 0.02 | 0.087 | Exportin-1 inhibitor | 0.087 0.018 CID_9816279 | CID_9816279 | |
| 0.177 | 0.113 | 0.177 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.096 | 0.033 | 0.096 | Caspase 7 inhibitor | |||
| 0.07 | 0.006 | 0.07 | Dihydrofolate reductase inhibitor | |||
| 0.072 | 0.009 | 0.072 | Immunoglobulin Fc receptor antagonist | |||
| 0.127 | 0.065 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.09 CID_9816279 | ||
| 0.096 | 0.033 | 0.096 | Histidine decarboxylase inhibitor | 0.081 0.042 CID_9816279 | ||
| 0.112 | 0.05 | 0.141 | Carbonic anhydrase III inhibitor | 0.141 0.032 CID_9816279 | CID_9816279 | |
| 0.118 | 0.056 | 0.168 | Mucolytic | 0.168 0.024 CID_9816279 | CID_9816279 | |
| 0.191 | 0.129 | 0.234 | Interleukin agonist | 0.234 0.091 CID_9816279 | CID_9816279 | |
| 0.08 | 0.02 | 0.08 | Phosphodiesterase 4A inhibitor | 0.048 0.036 CID_9816279 | ||
| 0.144 | 0.086 | 0.144 | Hexokinase inhibitor | |||
| 0.098 | 0.039 | 0.098 | Glutathione S-transferase inhibitor | 0.086 0.052 CID_9816279 | ||
| 0.138 | 0.08 | 0.148 | Ca2+-transporting ATPase inhibitor | 0.148 0.047 CID_9816279 | CID_9816279 | |
| 0.141 | 0.083 | 0.319 | Peroxidase inhibitor | 0.319 0.034 CID_9816279 | CID_9816279 | |
| 0.06 | 0.003 | 0.06 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.02 CID_9816279 | ||
| 0.088 | 0.033 | 0.088 | Leukotriene synthesis inhibitor | 0.074 0.041 CID_9816279 | ||
| 0.173 | 0.118 | 0.173 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.084 | 0.029 | 0.084 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.087 | 0.033 | 0.087 | Calcium channel L-type blocker | |||
| 0.086 | 0.033 | 0.086 | Amidase inhibitor | |||
| 0.069 | 0.016 | 0.069 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.095 | 0.043 | 0.095 | Acetylcholine nicotinic antagonist | |||
| 0.093 | 0.041 | 0.161 | Catalase inhibitor | 0.161 0.024 CID_9816279 | CID_9816279 | |
| 0.103 | 0.052 | 0.103 | Prolactin inhibitor | |||
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | 0.06 0.037 CID_9816279 | ||
| 0.058 | 0.007 | 0.058 | Heme oxygenase inhibitor | 0.047 0.018 CID_9816279 | ||
| 0.095 | 0.044 | 0.099 | Transcription factor NF kappa B stimulant | 0.099 0.039 CID_9816279 | CID_9816279 | |
| 0.084 | 0.034 | 0.09 | GABA B receptor agonist | 0.09 0.025 CID_9816279 | CID_9816279 | |
| 0.125 | 0.075 | 0.125 | Cyclooxygenase 2 inhibitor | |||
| 0.083 | 0.034 | 0.083 | Phosphodiesterase 4B inhibitor | 0.067 0.047 CID_9816279 | ||
| 0.091 | 0.042 | 0.091 | Chymotrypsin inhibitor | |||
| 0.056 | 0.008 | 0.056 | Melatonin agonist | |||
| 0.087 | 0.039 | 0.087 | Estrogen receptor alpha antagonist | 0.086 0.04 CID_9816279 | ||
| 0.102 | 0.054 | 0.102 | Breast cancer-resistant protein inhibitor | |||
| 0.056 | 0.009 | 0.056 | Melatonin 2 agonist | |||
| 0.073 | 0.026 | 0.073 | Transcription factor RelA inhibitor | |||
| 0.065 | 0.019 | 0.065 | Prolyl endopeptidase inhibitor | |||
| 0.069 | 0.023 | 0.069 | Sphingosine kinase 2 inhibitor | |||
| 0.157 | 0.11 | 0.157 | Psychostimulant | 0.139 0.126 CID_9816279 | ||
| 0.084 | 0.039 | 0.084 | Lipase inhibitor | |||
| 0.136 | 0.091 | 0.136 | Heat shock protein 70 antagonist | |||
| 0.116 | 0.072 | 0.116 | DNA polymerase I inhibitor | |||
| 0.134 | 0.091 | 0.154 | Cholinergic | 0.154 0.073 CID_9816279 | CID_9816279 | |
| 0.082 | 0.038 | 0.082 | Phosphodiesterase VI inhibitor | |||
| 0.052 | 0.008 | 0.052 | Free fatty acid receptor 1 antagonist | |||
| 0.087 | 0.043 | 0.087 | Phosphodiesterase 4D inhibitor | |||
| 0.048 | 0.005 | 0.048 | Adenosine uptake inhibitor | |||
| 0.063 | 0.02 | 0.067 | Lysophosphatidic acid 3 receptor antagonist | 0.067 0.017 CID_9816279 | CID_9816279 | |
| 0.079 | 0.037 | 0.079 | Neuronal nicotinic receptor antagonist | |||
| 0.101 | 0.06 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.103 0.058 CID_9816279 | CID_9816279 | |
| 0.05 | 0.009 | 0.05 | Melatonin 1 agonist | |||
| 0.061 | 0.02 | 0.061 | Potassium channel Kv1.3 blocker | 0.044 0.037 CID_9816279 | ||
| 0.078 | 0.038 | 0.078 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.112 | 0.073 | 0.217 | Anesthetic local | 0.217 0.028 CID_9816279 | CID_9816279 | |
| 0.052 | 0.013 | 0.059 | Diamine oxidase inhibitor | 0.059 0.01 CID_9816279 | CID_9816279 | |
| 0.102 | 0.064 | 0.108 | Gastric antisecretory | 0.108 0.055 CID_9816279 | CID_9816279 | |
| 0.063 | 0.026 | 0.063 | 5 Hydroxytryptamine 7 agonist | |||
| 0.062 | 0.025 | 0.062 | Leukotriene C antagonist | 0.058 0.034 CID_9816279 | ||
| 0.06 | 0.024 | 0.06 | Glucose-6-phosphate translocase inhibitor | |||
| 0.062 | 0.028 | 0.062 | Elastase inhibitor | |||
| 0.094 | 0.059 | 0.094 | Uric acid excretion stimulant | |||
| 0.098 | 0.064 | 0.098 | Nitric-oxide synthase inhibitor | |||
| 0.051 | 0.017 | 0.051 | Plasmepsin II inhibitor | |||
| 0.134 | 0.102 | 0.134 | Growth hormone agonist | |||
| 0.053 | 0.02 | 0.053 | Histone deacetylase 8 inhibitor | |||
| 0.036 | 0.004 | 0.036 | Melatonin receptor 1A antagonist | |||
| 0.046 | 0.016 | 0.046 | Squalene synthetase inhibitor | |||
| 0.113 | 0.086 | 0.174 | Amylase inhibitor | 0.174 0.054 CID_9816279 | CID_9816279 | |
| 0.052 | 0.025 | 0.052 | Cytokine production stimulant | 0.051 0.027 CID_9816279 | ||
| 0.053 | 0.026 | 0.053 | Cholesterol esterase inhibitor | |||
| 0.035 | 0.008 | 0.035 | CYP24 inhibitor | |||
| 0.034 | 0.007 | 0.034 | Hedgehog signaling activator | 0.028 0.017 CID_9816279 | ||
| 0.056 | 0.03 | 0.056 | Heparanase inhibitor | |||
| 0.09 | 0.065 | 0.09 | ABCA1 expression enhancer | |||
| 0.057 | 0.033 | 0.057 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.044 | 0.021 | 0.044 | Histone deacetylase 7 inhibitor | |||
| 0.042 | 0.019 | 0.042 | Nicotinic acid receptor agonist | |||
| 0.039 | 0.017 | 0.039 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.052 | 0.03 | 0.083 | Topoisomerase II beta inhibitor | 0.083 0.013 CID_9816279 | CID_9816279 | |
| 0.054 | 0.032 | 0.054 | Vanilloid 2 antagonist | |||
| 0.045 | 0.024 | 0.045 | Liver X receptor alpha agonist | |||
| 0.06 | 0.039 | 0.06 | Sphingosine kinase inhibitor | |||
| 0.081 | 0.06 | 0.101 | Inducible nitric-oxide synthase inhibitor | 0.101 0.036 CID_9816279 | CID_9816279 | |
| 0.042 | 0.02 | 0.313 | Estrogen receptor alpha agonist | 0.313 0.003 CID_9816279 | CID_9816279 | |
| 0.065 | 0.044 | 0.082 | CDC25B inhibitor | 0.082 0.026 CID_9816279 | CID_9816279 | |
| 0.072 | 0.051 | 0.072 | Aminopeptidase I inhibitor | |||
| 0.079 | 0.058 | 0.079 | Carbonic anhydrase VI inhibitor | 0.079 0.058 CID_9816279 | ||
| 0.107 | 0.086 | 0.124 | Cholinergic antagonist | 0.124 0.07 CID_9816279 | CID_9816279 | |
| 0.088 | 0.068 | 0.088 | MAO B inhibitor | |||
| 0.034 | 0.013 | 0.034 | Melatonin antagonist | |||
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.041 | 0.022 | 0.041 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.06 | 0.04 | 0.06 | Beta tubulin antagonist | |||
| 0.086 | 0.066 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.067 | 0.047 | 0.067 | Acetylcholine M5 receptor agonist | |||
| 0.048 | 0.029 | 0.048 | Carbonic anhydrase VII inhibitor | |||
| 0.066 | 0.047 | 0.066 | Phosphodiesterase III inhibitor | |||
| 0.057 | 0.039 | 0.06 | Pregnane X receptor antagonist | 0.06 0.03 CID_9816279 | CID_9816279 | |
| 0.045 | 0.027 | 0.048 | Guanylate cyclase inhibitor | 0.048 0.023 CID_9816279 | CID_9816279 | |
| 0.112 | 0.094 | 0.112 | Bone formation stimulant | |||
| 0.064 | 0.047 | 0.064 | Histone deacetylase inhibitor | |||
| 0.069 | 0.051 | 0.069 | Secretase beta inhibitor | |||
| 0.094 | 0.078 | 0.111 | Adenylate kinase inhibitor | 0.111 0.052 CID_9816279 | CID_9816279 | |
| 0.095 | 0.079 | 0.095 | Toll-Like receptor 4 antagonist | 0.091 0.087 CID_9816279 | ||
| 0.103 | 0.087 | 0.103 | Caspase 3 inhibitor | |||
| 0.02 | 0.004 | 0.02 | Calcium-dependent phospholipase A2 inhibitor | |||
| 0.093 | 0.077 | 0.153 | Expectorant | 0.153 0.034 CID_9816279 | CID_9816279 | |
| 0.053 | 0.038 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.05 | 0.035 | 0.239 | Estrogen agonist | 0.239 0.007 CID_9816279 | CID_9816279 | |
| 0.067 | 0.052 | 0.067 | Elastase 1 inhibitor | |||
| 0.048 | 0.033 | 0.059 | Peroxisome proliferator-activated receptor alpha agonist | 0.059 0.027 CID_9816279 | CID_9816279 | |
| 0.151 | 0.136 | 0.26 | Hypolipemic | 0.26 0.063 CID_9816279 | CID_9816279 | |
| 0.055 | 0.04 | 0.077 | Beta 1 adrenoreceptor antagonist | 0.077 0.02 CID_9816279 | CID_9816279 | |
| 0.019 | 0.004 | 0.019 | Melatonin 2 antagonist | 0.011 0.01 CID_9816279 | ||
| 0.089 | 0.075 | 0.089 | Protease inhibitor | |||
| 0.039 | 0.025 | 0.039 | Leukotriene C4 antagonist | 0.037 0.034 CID_9816279 | ||
| 0.092 | 0.079 | 0.092 | Estrogen receptor beta antagonist | 0.092 0.079 CID_9816279 | ||
| 0.101 | 0.088 | 0.101 | Beta amyloid protein antagonist | |||
| 0.102 | 0.089 | 0.117 | Acetylcholine antagonist | 0.117 0.073 CID_9816279 | CID_9816279 | |
| 0.021 | 0.009 | 0.021 | G-protein-coupled receptor 120 agonist | |||
| 0.063 | 0.05 | 0.097 | Beta adrenoreceptor antagonist | 0.097 0.018 CID_9816279 | CID_9816279 | |
| 0.039 | 0.027 | 0.039 | Histone deacetylase 9 inhibitor | |||
| 0.021 | 0.009 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 CID_9816279 | CID_9816279 | |
| 0.062 | 0.05 | 0.081 | Beta 3 adrenoreceptor antagonist | 0.081 0.022 CID_9816279 | CID_9816279 | |
| 0.038 | 0.026 | 0.038 | 5-Alpha-reductase inhibitor | |||
| 0.08 | 0.068 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.077 0.076 CID_9816279 | ||
| 0.034 | 0.022 | 0.034 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.079 | 0.068 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.079 | 0.068 | 0.079 | CC chemokine 5 receptor agonist | |||
| 0.049 | 0.038 | 0.05 | Factor III inhibitor | 0.05 0.033 CID_9816279 | CID_9816279 | |
| 0.067 | 0.057 | 0.067 | Cathepsin G inhibitor | |||
| 0.021 | 0.011 | 0.021 | Melatonin 1 antagonist | |||
| 0.055 | 0.046 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.031 | 0.021 | 0.044 | Prostaglandin agonist | 0.044 0.012 CID_9816279 | CID_9816279 | |
| 0.108 | 0.099 | 0.108 | Nav1.2 sodium channel blocker | |||
| 0.081 | 0.072 | 0.081 | Falcipain inhibitor | |||
| 0.039 | 0.03 | 0.039 | Dopamine D5 agonist | |||
| 0.091 | 0.082 | 0.091 | Glutamate (mGluR7) agonist | 0.091 0.082 CID_9816279 | ||
| 0.026 | 0.018 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CID_9816279 | CID_9816279 | |
| 0.085 | 0.077 | 0.085 | Aminopeptidase B inhibitor | |||
| 0.042 | 0.035 | 0.042 | Dihydroorotase inhibitor | |||
| 0.046 | 0.039 | 0.046 | Cannabinoid CB2 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.025 | 0.018 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.024 0.021 CID_9816279 | ||
| 0.078 | 0.072 | 0.078 | Falcipain 2 inhibitor | |||
| 0.138 | 0.133 | 0.138 | Phospholipase C inhibitor | |||
| 0.025 | 0.02 | 0.025 | Acid ceramidase inhibitor | |||
| 0.054 | 0.049 | 0.086 | Acetylcholine M3 receptor antagonist | 0.086 0.023 CID_9816279 | CID_9816279 | |
| 0.036 | 0.031 | 0.036 | Histone deacetylase class I inhibitor | |||
| 0.028 | 0.024 | 0.028 | Thiazolidinedione | |||
| 0.098 | 0.094 | 0.114 | Microtubule formation inhibitor | 0.114 0.068 CID_9816279 | CID_9816279 | |
| 0.025 | 0.021 | 0.046 | Leukotriene B4 receptor 1 antagonist | 0.046 0.009 CID_9816279 | CID_9816279 | |
| 0.029 | 0.026 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.03 | 0.026 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.063 | 0.06 | 0.063 | HIV-1 integrase inhibitor | |||
| 0.031 | 0.028 | 0.032 | Fumarate hydratase inhibitor | 0.032 0.026 CID_9816279 | CID_9816279 | |
| 0.116 | 0.114 | 0.189 | Acetylcholine M1 receptor antagonist | 0.189 0.047 CID_9816279 | CID_9816279 | |
| 0.088 | 0.086 | 0.1 | Ferrochelatase inhibitor | 0.1 0.071 CID_9816279 | CID_9816279 | |
| 0.029 | 0.027 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.051 | 0.049 | 0.051 | Cathepsin L inhibitor | |||
| 0.038 | 0.036 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.16 | 0.158 | 0.16 | DNA damaging | |||
| 0.033 | 0.033 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 CID_9816279 | CID_9816279 | |
| 0.065 | 0.064 | 0.065 | Acetylcholine M4 receptor antagonist | |||
| 0.027 | 0.028 | 0.052 | Prostaglandin D2 agonist | 0.052 0.007 CID_9816279 | CID_9816279 | |
| 0.099 | 0.101 | 0.1 | Estrogen antagonist | 0.1 0.099 CID_9816279 | CID_9816279 | |
| 0.061 | 0.065 | 0.062 | Glutamate (mGluR6) antagonist | 0.062 0.059 CID_9816279 | CID_9816279 | |
| 0.094 | 0.098 | 0.137 | Acetylcholine muscarinic antagonist | 0.137 0.053 CID_9816279 | CID_9816279 | |
| 0.018 | 0.023 | 0.03 | Lysophosphatidic acid 1 receptor antagonist | 0.03 0.006 CID_9816279 | CID_9816279 | |
| 0.078 | 0.083 | 0.094 | ATPase (Vacuolar H+) inhibitor | 0.094 0.049 CID_9816279 | CID_9816279 | |
| 0.061 | 0.067 | 0.101 | Glutamate decarboxylase inhibitor | 0.101 0.029 CID_9816279 | CID_9816279 | |
| 0.069 | 0.076 | 0.077 | Sphingosine 1-phosphate receptor antagonist | 0.077 0.051 CID_9816279 | CID_9816279 | |
| 0.051 | 0.058 | 0.088 | Acetylcholine M5 receptor antagonist | 0.088 0.021 CID_9816279 | CID_9816279 | |
| 0.044 | 0.051 | 0.052 | Aconitate hydratase inhibitor | 0.052 0.036 CID_9816279 | CID_9816279 | |
| 0.121 | 0.128 | 0.135 | Pregnane X receptor agonist | 0.135 0.086 CID_9816279 | CID_9816279 | |
| 0.075 | 0.086 | 0.094 | Triose-phosphate isomerase inhibitor | 0.094 0.054 CID_9816279 | CID_9816279 | |
| 0.09 | 0.101 | 0.103 | Alkylator | 0.103 0.085 CID_9816279 | CID_9816279 | |
| 0.016 | 0.028 | 0.024 | Prostaglandin E2 agonist | 0.024 0.015 CID_9816279 | CID_9816279 | |
| 0.079 | 0.091 | 0.138 | Urease inhibitor | 0.138 0.03 CID_9816279 | CID_9816279 | |
| 0.024 | 0.037 | 0.042 | Cholesterol ester transfer protein antagonist | 0.042 0.012 CID_9816279 | CID_9816279 | |
| 0.051 | 0.065 | 0.055 | Lipocortins synthesis agonist | 0.055 0.048 CID_9816279 | CID_9816279 | |
| 0.093 | 0.112 | 0.12 | Alpha-N-acetylglucosaminidase inhibitor | 0.12 0.077 CID_9816279 | CID_9816279 | |
| 0.037 | 0.057 | 0.056 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 CID_9816279 | CID_9816279 | |
| 0.038 | 0.059 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 CID_9816279 | CID_9816279 | |
| 0.046 | 0.069 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.036 CID_9816279 | CID_9816279 | |
| 0.055 | 0.078 | 0.066 | Beta 2 adrenoreceptor agonist | 0.066 0.028 CID_9816279 | CID_9816279 | |
| 0.05 | 0.074 | 0.083 | Phenylalanine 4-hydroxylase inhibitor | 0.083 0.035 CID_9816279 | CID_9816279 | |
| 0.057 | 0.081 | 0.065 | Glutamate dehydrogenase inhibitor | 0.065 0.064 CID_9816279 | CID_9816279 | |
| 0.021 | 0.046 | 0.033 | Lysophosphatidic acid 2 receptor antagonist | 0.033 0.018 CID_9816279 | CID_9816279 | |
| 0.008 | 0.035 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_9816279 | CID_9816279 | |
| 0.096 | 0.126 | 0.19 | Interleukin 4 antagonist | 0.19 0.025 CID_9816279 | CID_9816279 | |
| 0.076 | 0.108 | 0.134 | Toll-Like receptor 3 antagonist | 0.134 0.021 CID_9816279 | CID_9816279 | |
| 0.011 | 0.045 | 0.204 | Estrogen receptor beta agonist | 0.204 0.005 CID_9816279 | CID_9816279 | |
| 0.01 | 0.046 | 0.028 | Prostaglandin EP2 agonist | 0.028 0.013 CID_9816279 | CID_9816279 | |
| 0.037 | 0.079 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.027 CID_9816279 | CID_9816279 | |
| 0.032 | 0.085 | 0.064 | Acetylcholine M2 receptor antagonist | 0.064 0.042 CID_9816279 | CID_9816279 | |
| 0.12 | 0.188 | 0.176 | Immunostimulant | 0.176 0.135 CID_9816279 | CID_9816279 | |
| 0.02 | 0.094 | 0.035 | Ceramide glucosyltransferase inhibitor | 0.035 0.025 CID_9816279 | CID_9816279 | |
| 0.063 | 0.138 | 0.1 | Topoisomerase II inhibitor | 0.1 0.086 CID_9816279 | CID_9816279 | |
| 0.025 | 0.102 | 0.074 | Prostaglandin EP2 antagonist | 0.074 0.03 CID_9816279 | CID_9816279 | |
| 0.048 | 0.127 | 0.102 | Adrenaline agonist | 0.102 0.036 CID_9816279 | CID_9816279 | |
| 0.029 | 0.131 | 0.084 | Factor IXa inhibitor | 0.084 0.014 CID_9816279 | CID_9816279 | |
| 0.023 | 0.138 | 0.108 | Neuraminidase inhibitor | 0.108 0.013 CID_9816279 | CID_9816279 | |
| 0.162 | 0.279 | 0.273 | Antibacterial | 0.273 0.157 CID_9816279 | CID_9816279 | |
| 0.116 | 0.243 | 0.192 | Hypoglycemic | 0.192 0.12 CID_9816279 | CID_9816279 | |
| 0.052 | 0.209 | 0.153 | Interleukin 5 antagonist | 0.153 0.01 CID_9816279 | CID_9816279 | |
| 0.062 | 0.273 | 0.127 | MAP3K9 inhibitor | 0.127 0.1 CID_9816279 | CID_9816279 | |
| 0.027 | 0.239 | 0.089 | Adrenaline antagonist | 0.089 0.06 CID_9816279 | CID_9816279 | |
| 0.028 | 0.241 | 0.092 | Antiadrenergic | 0.092 0.061 CID_9816279 | CID_9816279 | |
| 0.007 | 0.235 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_9816279 | CID_9816279 | |
| 0.139 | 0.383 | 0.234 | Cyclophilin D inhibitor | 0.234 0.231 CID_9816279 | CID_9816279 | |
| 0.018 | 0.268 | 0.14 | Neuraminidase (influenza) inhibitor | 0.14 0.009 CID_9816279 | CID_9816279 | |
| 0.102 | 0.469 | 0.206 | Interleukin 2 agonist | 0.206 0.178 CID_9816279 | CID_9816279 | |
| 0.073 | 0.678 | 0.254 | Peptidyltransferase inhibitor | 0.254 0.048 CID_9816279 | CID_9816279 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |